News Focus
News Focus
icon url

dennisdave

03/12/25 11:21 AM

#753766 RE: FeMike #753760

I 100% agree with you Mike
icon url

Kap10jak

03/12/25 11:23 AM

#753767 RE: FeMike #753760

Red hot moments can be expensive.
Bullish
Bullish
icon url

Guzzi62

03/12/25 11:28 AM

#753773 RE: FeMike #753760

I wish we could send all this you wrote there direct to Linda P. and demand an explanation?

What on earth is going on here??
icon url

manibiotech

03/12/25 11:34 AM

#753776 RE: FeMike #753760

You forgot Advent progress
icon url

KRISGO

03/12/25 11:35 AM

#753777 RE: FeMike #753760

I totally agree, and this is exactly what I was saying. No one can question them about accountability? I’m starting to wonder if this is a public or private company.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175866174
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175811442
icon url

dennisdave

03/12/25 12:06 PM

#753792 RE: FeMike #753760

$66 million for company with 20 employees. + Advent a Toucan subsidiary of 84 highly educated and thus highly paid staff
icon url

10baggerz

03/12/25 12:29 PM

#753802 RE: FeMike #753760

You know I respect your perspective, share your frustration, and recognize that you’ve been one of the only actual shareholders that has been right about the share price; however, there is an error in the statement that NWBO has SOLD $66 MILLION worth of shares in the past year.

Yes, the OS went up by 189,000,000 shares, but that doesn’t mean NWBO diluted those shares THIS YEAR. We already knew many years ago that they had issued about 1.5 BILLION shares in the form of warrants from past offerings. Those shares are primarily the result of the exercise of such warrants AKA PAST DILUTION.

Not defending management, just saying that they didn’t burn through $66 million in dilutive cash over the last year.
icon url

Doc logic

03/12/25 3:35 PM

#753883 RE: FeMike #753760

FeMike,

In your estimation how many Eden units might be needed for ramp up preparation and training if a partnership of some sort was involved with a post approval announcement with expectations for commercial use by early to mid 2016 in at least one jurisdiction and do you think UCLA and other licensed facilities might want to start their use of same for trials? I ask because if trials will be starting with Flaskworks obviously Advent can’t handle all that demand along with demand from UK patients and off label Specials use too. Best wishes.